Cultures of tetracycline-treated Staphylococcus aureus exhibited monophasic steady-state growth curves similar to that observed for tetracycline-treated Escherichia coli. Apparent growth rate constants of the respective drug-treated cultures showed the same formal dependence on drug concentration, which was linear at a low concentration but asymptotically approached zero at higher concentration levels and implied the saturation of a limited number of receptor sites engaged in microbial protein synthesis. The relative potency oftetracycline action ofS. aureuslE. coli was 6.50:1 at 37.5°C and pH 7.05. This is attributed to relative differences in drug permeation and/or binding affinity for biophase receptors in the respective organisms. It is concluded from kinetic dependencies ofgrowth inhibition ofthe cultures that tetracycline has the same mode ofaction on S. aureus and E. coli. It is bacteriostatic at concentrations below the minimal inhibitory concentration level but bactericidal at the higher concentration levels.
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Tetracycline is a broad-spectrum antibiotic, which is active against gram-positive cocci and some gram-negative organisms, in addition to rickettsias and clamydia (15) . It has been shown to bind to the 30S ribosomal subunit (5, 18, 22, 23, 29) and to inhibit the formation of peptide linkages in microbial protein synthesis (4, 21, 27, 29) . Tetracycline is reported to produce bacteriostatic effects on microorganisms, even though high concentrations of the drug have shown bactericidal effects (15) .
The relative potency of the tetracyclines against susceptible and resistant strains of organisms (15) has been attributed to differences in the drug permeation through cell membranes, which result in increased ability of susceptible strains to accumulate the drug in the biophase (6-8, 19, 25, 28) . Since tetracycline is more active against Staphylococcus aureus than against Escherichia coli (15) , it would be expected that the drug would have a higher partitioning and/or binding affinity for biophase receptors in the former than in the latter organism.
Studies on the action of tetracycline against E. coli by the kinetics of microbial growth (2, (10) (11) (12) (13) (14) 24) permitted not only the characterization of drug-receptor interactions in the biophase but also an elucidation of the possible mode of tetracycline action on the cells. Recently, comparative studies on the action of some drugs on S. aureus and E. coli by microbial growth kinetics (16) have revealed relative differences in the kinetics and dependencies related to modes of drug action on gram-positive and gram-negative organisms. This paper presents the results of similar studies on tetracycline action. It considers the functional dependency of kinetic parameters, derived from growth inhibition of the cultures, on tetracycline concentrations, the inoculum size, broth constituents, and other varying conditions. In addition, the modes of tetracycline action in the subinhibitory concentration range and at high concentrations above the minimal inhibitory concentration (MIC) values are considered.
MATERIALS AND METHODS Antibiotics. Assayed samples of tetracycline hydrochloride (U.S.P.), supplied by courtesy of the Upjohn Co., were used for the experiments. The concentrations employed in all experiments refer to the hydrochloride salt of the antibiotic. Stock solutions were aseptically prepared by membrane filtration and stored at 40C. in a thermostatically controlled shaker water bath (model R. W. 65, New Brunswick Scientific Co.) to a cell count of 2 x 107/ml. A portion of this culture (1.0 ml ofS. aureus cultures per 50 ml of broth or 1.0 ml ofE. coli culture per 100 ml of broth) was added to a bulk amount of broth contained in a 500-ml Pyrex flask fitted with a 50-ml dispenser to form the "seeded" broth. This was incubated at 37.50C for 30 min with intermittent shaking. Quantities (50 ml) of the "seeded" broth were then aseptically transferred with the aid of the dispenser into replicate sterile Erlenmeyer flasks and maintained at 37.5°C in the shaker water bath. A portion (0.5 ml) of the suitably diluted tetracycline solution was added to each culture to yield a desired concentration of the antibiotic. The solution was added when the culture in the flask reached the logarithmic phase of growth at a cell concentration of 2.0 x 106/ml. The culture without antibiotic served as the control.
Viable count methods. Samples (1.0 ml) of drugfree and drug-treated cultures were withdrawn at 30-min intervals and diluted serially in sterile 0.9% NaCl and finally in broth to a cell concentration of 50 to 150/ml. Portions (1.0 ml) from the final broth dilution were plated in each of three replicate sandwich agar plates and incubated at 37.50C for 48 h. The bacterial colonies were counted on the colony counter (Lab-line Instruments, Inc.).
Total count methods. Samples (0.25 to 1.0 ml) of drug-free and drug-treated cultures were withdrawn at 30-min intervals and diluted in Formol-saline to obtain counts within a range of 2,000 to 70,000 counts/50 ,ul on a particle-size counter (Coulter counter, model ZB1, Coulter Electronics Co.) that was equipped with a 30-,um orifice. The settings of the instrument were: 1/aperture current, 1.0; 1/amplification, 1/2; gain, 8.0; matching switch, 40 K; lower threshold, 5; and upper threshold, at maximum. The Formol-saline diluent was 0.85% sodium chloride in 1.0% formaldehyde, filtered twice through a 0.2-,um membrane filter (GA-8 type, Metricel), which promptly arrested growth of the culture sample without lytic or clumping effects on the cells.
RESULTS
Shape of growth curves. The steady-state generation of S. aureus and E. coli cultures affected with graded concentrations of tetracycline demonstrated linear semilogarithmic plots in accordance with the expression: logN = log N0 + kapp t/2.303
(1) where N is the number of organisms per milliliter at anytime (t), No is the number of organisms per milliliter at some initial time (0), and kapp is the apparent generation rate constant. In all cases, the tetracycline-treated cultures showed an initial lag phase of approximately 30 min before emerging into a steadystate phase of growth. Figure 1 shows typical monophasic generation curves of tetracyclineaffected S. aureus, determined by the total count method. The curves are similar to those obtained for E. coli and confirm previous observations (2, 10-14, 16, 24) .
Functional dependency of apparent growth rate constants on drug concentrations. The relationship between the kapp and the tetracycline concentration is plotted in Fig. 2 . There was a linear dependency in the low concentration range from 0 to 0.075 gg/ml for tetracycline action on E. coli (curve A) and from 0 to 0.02 ,ug/ml for its action on S. aureus (curve B) in accordance with the expression (2, 10-13, 24):
where k, is the specific inhibitory rate constant and T is tetracycline concentration. In the absence of drug, kapp = k),, which is the growth higher concentration levels, the kapp was not a linear function of increasing tetracycline concentration but asymptotically approached zero. The plots ofTI(ko -kapp) versus T (Fig. 3) were reasonably linear for the action of tetracycline concentrations >0.075 ,ug/ml on E. coli (curve A) and >0.02 ug/ml on S. aureus (curve B), but showed deviations at the lower concentration levels. This implied quantitative adherence of the action of tetracycline on E. coli and S. aureus to an expression previously derived from a saturation kinetic model (13):
T/(ko-kapp) = T(ka/k&) + 1/ka (3) where ka and kb are constants of proportionality related to the tetracycline partition through cell membranes and its binding affinity for biophase receptors. At the MIC, when kapp = 0, equation 3 simplifies to: Tm = 1/(ka/ko -kb) (4) where Tm is the MIC for tetracycline.
The values of ka and kj, derived from the slopes and intercepts of the plots in Fig. 3 , and the Tm, calculated in accordance with equation 4, are given in Table 1 .
Effect of the counting method on growth curves. Semilogarithmic plots of total and viable These observations clearly indicated that the action of tetracycline was bactericidal at concentrations above the MIC. Similar results were obtained for the action of tetracycline on E. coli (12) .
Effect of changes in inoculum size and broth composition on apparent growth rates of tetracycline-treated cultures. The apparent growth rate constants for S. aureus cultures that were treated with 0, 0.01, 0.02, 0.04, 0.06, and 0.08 jig of tetracycline per ml, respectively, did not show significant variations from those obtained at corresponding concentration levels in Fig. 2 , when either (i) the inoculum size was changed 0.1-to 10.0-fold at the time of drug addition in a single-strength broth, or (ii) the broth composition was changed 0.5-to 2.0-fold with the organism population fixed at 2.0 x 106/ml at the time of drug addition.
DISCUSSION
There was no dependence of the apparent growth rate constants of drug-treated S. aureus on variations in the broth composition or the inoculum size at the time of drug addition, suggesting drug interaction with broth constituents or drug depletion/inactivation by microbial metabolic activities as was similarly observed (12) for the action of tetracycline on E. coli.
The parallelism of growth curves, obtained by the total and viable counts, indicates suitability of either method for determining growth rates of drug-free and drug-treated S. aureus cultures. It also provides evidence that there was no killing or lytic phenomenon superimposed on normal growth inhibition by the action of subinhibitory concentrations oftetracycline on S. aureus. Therefore, tetracycline exerts a "true bacteriostatic" action (3) on S. aureus, causing a decrease in the rate of cell multiplication, presumably by competitive binding on ribosomes to lower cell protein synthesis. At concentrations above the inhibitory level, the total count remains invariant with time, but the viable count decreased logarithmically with time as a function of tetracycline concentration. If the death of the organism was due to effects of prolonged bacteriostasis, then the death rate should show deviation from the monomolecular law (17, 20, 26, 30) . The fact that there is an exponential relationship between the v'iable count and drug-bacteria contact time suggests a bactericidal phenomenon.
The formal dependence of kapp on drug concentration for tetracycline-treated S. aureus is the same as the tetracycline-treated E. coli (Fig. 2) and suggests the same mechanism of action.
The relationship is described by a kinetic expression that is derived from model compartmental analysis (13) on the premise that: (i) the rate of increase in microbial numbers (dN/dt) is proportional to the net rate of protein synthesis (dp'/dt) above a certain minimum rate (Ap) required for survival and the numbers of organisms (N) present, and (ii) the overall rate of protein synthesis (dp/dt) is proportional to the free or unbound fraction (1 -0) of total ribosomal sites, RT, where 0 is the fraction of total ribosomal sites bound by tetracycline. Therefore, the following equations are applicable: dN/dt = km(dp'/dt)N = km(dp/dtAp)N = kapp N and dp/dt = q (1 -0)RT (5) 
where k, and q are constants of proportionality, and kapp is the growth rate constant of tetracycline-treated cultures. 0 is implicitly defined (9, 13) as follows:
where K, is tetracycline partition constant through cell membranes, and K2 is the ribosomal affinity constant for tetracycline (T). A combination of equations 5, 6, and 7 yields:
where k0 = q kmRT -km Ap is the growth rate constant of the drug-free culture, kb = KK2, and ka = q kmRTKlK2.
Therefore (ka/kb)/ko > 1 (9) Equation 8 may describe the functional dependency of the kapp on drug concentration for tetracycline-treated S. aureus and E. coli, respectively (Fig. 2) . The action of low concentrations (0 to 0.02 ,ug/ml) of tetracycline on S. aureus or (0 to 0.75 ,ug/ml) oftetracycline on E. Fig. 3 from the data of Fig. 2 at the high concentration levels. This indicates quantitative adherence to a saturation kinetic model (13) . Deviations occur in the low concentration range when the receptor sites are not saturated and the extent of growth inhibition (ko -kapp) is directly proportional to drug concentration. In earlier studies oftetracycline action on E. coli, a linear dependence ofthe kapp on drug concentration that could be quantified by equation 2 was reported (2, 10, 12, 13). The apparent discrepancy could be attributed to the fact that earlier studies did not employ a wider concentration than was presently investigated. Al 
where 6,,, is a fraction of total ribosomal sites bound by tetracycline. Therefore, 1 -On is the fraction engaged in the minimum rate of protein synthesis for survival. Tm is the MIC, as defined in equation 4. Table 1 shows that O., calculated from kinetic parameters for the action of tetracycline, competitively binds 85% of transfer ribonucleic acid-binding sites to produce true bacteriostasis (12) on the organisms. At concentrations greater than the MIC, there must be a change in the overt mechanism of tetracycline action that results in a change from truly bacteriostatic to a highly bactericidal agent, as observed experimentally (Fig. 4) . 
